OrderlyMeds vs Fifty 410
All-in cost at every dose, fee structure, care model, pharmacy disclosure and terms — compared on one basis.
Only OrderlyMeds publishes a price we could capture ($1,788 for a first year at a maintenance dose). The other does not, so this comparison cannot be settled on cost.
What can be compared is what each discloses: visit model, pharmacy identity, laboratory requirement and cancellation terms. Those are below.
All-in monthly cost = medication + any recurring fee, at a named dose, before tax and before prepaid discounts. Captured 2026-08-05. How we verify a price.
OrderlyMeds vs Fifty 410 at every dose
A single headline figure assumes a maintenance dose neither you nor your prescriber has chosen yet. This is the same comparison at all six strengths.
Trustpilot rating 3.6 from 622 reviews at capture, with 28% of reviewers awarding one star. Named reviewers describe undelivered prescriptions, refused refunds, unreachable support and long shipping delays. One review alleges sterile-compounding practices inconsistent with USP <797>; the company replied that it could not identify or verify the experience described and requested further detail. We report these as allegations we have not independently verified.
We have not independently verified these accounts and they are not a finding of wrongdoing. They are a documented public pattern, and a reader comparing prices should weigh them against a saving of a few dollars a month. Check the review platform and FDA warning letters yourself before enrolling.
OrderlyMeds against Fifty 410 at every dose
| Dose | OrderlyMeds | Fifty 410 | Cheaper |
|---|---|---|---|
| 0.25 mg | $149 | — | — |
| 0.5 mg | $149 | — | — |
| 1 mg | $149 | — | — |
| 1.7 mg | $149 | — | — |
| 2.4 mg | $149 | — | — |
What differs beyond price
Price is the easiest thing to compare and rarely the thing that decides satisfaction. These are the attributes each programme publishes.
| Attribute | OrderlyMeds | Fifty 410 |
|---|---|---|
| Pricing model | flat at every dose | model unknown |
| Membership | none | none |
| Prepaid rate | none published | none published |
| Visit model | async | not published |
| Labs | not required | not published |
| Pharmacy disclosure | not named | not published |
| Cancellation | not published | not published |
| Regulatory status | compounded, not FDA-approved | compounded, not FDA-approved |
| Evidence status | third-party figure | no price published |
Which one, for whom
If you want the lowest total cost: neither can be ranked on cost until both publish a price.
If you want budget certainty: OrderlyMeds, which holds one price at every strength.
If you want to verify the supply chain: OrderlyMeds, which names its dispensing pharmacy.
If you may need to stop early: compare the cancellation rows above before prepaying. Compounded medication is generally not refundable once it has shipped, so a multi-month term is the wrong structure during titration, when intolerance is the most likely reason to stop.
Switching between them
Usually possible after a clinical review, and the two real risks are a supply gap while a new intake is processed and a new prescriber restarting titration rather than continuing your dose. Confirm dose continuity in writing before cancelling anything, because a month back at 0.25 mg is a month of lost progress no price difference recovers.
Fee structure, side by side
OrderlyMeds charges no recurring fee on top of medication. Fifty 410 charges no recurring fee.
This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.
Care model and what it buys
OrderlyMeds: async, labs not required, none published. Fifty 410: visit model not published, labs not published, coaching not published.
Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.
Verification, which outranks both
OrderlyMeds: not named. Fifty 410: pharmacy not disclosed.
A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.
What can still be decided here
Without a price on both sides this cannot be settled on cost, so it has to be settled on what each programme publishes — which is frequently the better basis anyway.
OrderlyMeds publishes: visit model async, laboratory requirement not required, pharmacy not named, cancellation not published. Fifty 410 publishes: visit model not stated, laboratory requirement not stated, pharmacy not stated, cancellation not stated.
A programme publishing four of those and one publishing none are not equally knowable, and that asymmetry is a finding rather than a gap in our research. Ask both for the total at 2.4 mg including every fee, in writing, and see which answers.
Why a missing price is itself information
A programme that publishes its price is making a claim it can be held to. A programme that reveals cost only after an intake has made a commercial choice: it wants your contact details and a medical history before you can compare it against anything.
That is legal and common. It is also why several pages on this site carry an explanation instead of a number. Estimating would mean inventing the only figure that matters, and every time we have checked an estimate published elsewhere against a provider's own page, the estimate was low.
The short version of orderlymeds and fifty 410
Price the dose you expect to hold, not the one in the advertisement. Add every recurring fee. Verify the pharmacy. Everything else on this page is detail underneath those three.
Done properly the answer is usually one of a handful of programmes: the cheapest verified route runs $145 a month all-in, about $1,740 across a first year including titration.
The next step that actually moves things
Send two or three programmes the same five questions: total at 2.4 mg including every fee, which pharmacy, is the prescriber licensed in my state, what notice to cancel and what is refundable, and which form of the active ingredient is used.
Whoever answers all five in writing has told you more than any comparison table can, this one included. Whoever does not has also told you something.
One thing worth doing annually
Re-price the market at your actual maintenance dose. No programme notifies existing patients when a competitor drops below it, and semaglutide pricing moved repeatedly through 2025 and 2026 — manufacturer cuts, an oral option, a higher-dose product, and several platforms leaving compounded entirely.
An hour once a year is a poor use of time for most purchases and an excellent one for a medication you may take for years.
What the spread actually represents
All-in cost runs $145 to $324 a month for the same molecule from the same category of licensed pharmacy. That gap is not the medicine. It is overhead, clinical wrap, sourcing and margin, plus how aggressively a programme is willing to structure its fees.
4 of 20 charge a mandatory recurring fee and 19 hold one price at every strength. Those two facts explain most of the spread, and neither appears in a headline figure.
Where our numbers could be wrong
A programme changed its price after our capture date. A third-party figure we recorded does not survive checking. A promotional rate was published as a standing one. Or a programme publishes something we could not find.
All four are live risks and the first is near-certain over time. Every figure carries its capture date and a link to the source we read, so the check takes about two minutes and does not require trusting us.
Why the cheapest entries are the least reliable
Four distortions push in the same direction: a promotional first month quoted as a standing rate, a prepaid bundle rate quoted as monthly, a medication figure that excludes a mandatory membership, and occasionally a different molecule's price in the wrong column.
Every one of those makes a programme look cheaper than it is, which is why the bottom of any published table is where errors concentrate. It is also why we mark which figures we read at the provider and which we did not, rather than presenting one confident list.
Where we have been able to check an unconfirmed figure against a provider's own page, the number usually moved upward.
How to sanity-check any figure you find elsewhere
Three questions. What dose does it describe? Does it include every recurring fee? And when was it captured? A price failing any of the three is not comparable to the numbers here, and most published figures fail at least one.
Semaglutide makes this worse than most categories because the same molecule sells under several brands at prices spanning more than fifteenfold. 'Semaglutide costs X' is not a sentence that can be true without naming the product and the channel.
Why this comparison cannot be settled on price
Only OrderlyMeds publishes a price we could capture, at about $1,788 for a first year at a maintenance dose. The other does not. A comparison that filled that gap with an estimate would be inventing the only number that matters.
What can be compared is what each discloses before you pay, and that is frequently the more useful comparison anyway. A programme that names its pharmacy, states its cancellation terms and publishes a price at every dose has told you how it will behave when something goes wrong.
What to do instead
Ask both for the total at 2.4 mg including every fee, in writing, and compare the replies against the programmes that already publish. If one answers in a sentence and the other does not answer at all, you have your comparison.
Why we publish the page anyway
Because the absence is the finding. Someone searching for this pairing deserves to know that one side cannot be priced, rather than being shown a fabricated number or no page at all.
Fee structure, side by side
OrderlyMeds charges no recurring fee on top of medication. Fifty 410 charges no recurring fee.
This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.
Care model and what it buys
OrderlyMeds: async, labs not required, none published. Fifty 410: visit model not published, labs not published, coaching not published.
Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.
Verification, which outranks both
OrderlyMeds: not named. Fifty 410: pharmacy not disclosed.
A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.
What can still be decided here
Without a price on both sides this cannot be settled on cost, so it has to be settled on what each programme publishes — which is frequently the better basis anyway.
OrderlyMeds publishes: visit model async, laboratory requirement not required, pharmacy not named, cancellation not published. Fifty 410 publishes: visit model not stated, laboratory requirement not stated, pharmacy not stated, cancellation not stated.
A programme publishing four of those and one publishing none are not equally knowable, and that asymmetry is a finding rather than a gap in our research. Ask both for the total at 2.4 mg including every fee, in writing, and see which answers.
Why a missing price is itself information
A programme that publishes its price is making a claim it can be held to. A programme that reveals cost only after an intake has made a commercial choice: it wants your contact details and a medical history before you can compare it against anything.
That is legal and common. It is also why several pages on this site carry an explanation instead of a number. Estimating would mean inventing the only figure that matters, and every time we have checked an estimate published elsewhere against a provider's own page, the estimate was low.
The short version of orderlymeds and fifty 410
Price the dose you expect to hold, not the one in the advertisement. Add every recurring fee. Verify the pharmacy. Everything else on this page is detail underneath those three.
Done properly the answer is usually one of a handful of programmes: the cheapest verified route runs $145 a month all-in, about $1,740 across a first year including titration.
The next step that actually moves things
Send two or three programmes the same five questions: total at 2.4 mg including every fee, which pharmacy, is the prescriber licensed in my state, what notice to cancel and what is refundable, and which form of the active ingredient is used.
Whoever answers all five in writing has told you more than any comparison table can, this one included. Whoever does not has also told you something.
One thing worth doing annually
Re-price the market at your actual maintenance dose. No programme notifies existing patients when a competitor drops below it, and semaglutide pricing moved repeatedly through 2025 and 2026 — manufacturer cuts, an oral option, a higher-dose product, and several platforms leaving compounded entirely.
An hour once a year is a poor use of time for most purchases and an excellent one for a medication you may take for years.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.
Common questions
Is OrderlyMeds or Fifty 410 cheaper?
Only one of the two publishes a price we could capture, so this comparison cannot be settled on cost. Both are compared on terms and disclosure instead.
Do OrderlyMeds and Fifty 410 charge a membership on top of medication?
OrderlyMeds: no. Fifty 410: no. Every figure on this page includes it where charged.
Does OrderlyMeds or Fifty 410 name its dispensing pharmacy?
OrderlyMeds: not named. Fifty 410: not published. It is the disclosure that lets you check a state board register before you inject anything weekly.
Can I switch between them mid-treatment?
Usually yes, after a clinical review. Confirm dose continuity in writing and do not cancel the old programme until the new one has shipped, because a supply gap costs more than a price difference.
Is either OrderlyMeds or Fifty 410 FDA-approved?
Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before marketing. Where a programme supplies brand product, that product is approved; the programme around it is not a regulated entity in the same sense.